Lichen Planus Market Outlook 2026–2030 Exploring New Business Opportunities

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Lichen Planus Market Over The 2026–2030 Period?

The lichen planus market has shown strong expansion in recent years. It is projected to increase from $1.26 billion in 2025 to $1.35 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.1%. This historic growth is attributable to an increased diagnosis of autoimmune skin disorders, the availability of corticosteroid therapies, an expansion of dermatology specialty clinics, improved clinical awareness of lichen planus, and the use of phototherapy techniques.

The market for lichen planus is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $1.76 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.8%. Several factors contribute to this growth during the projected period, including an escalating demand for sophisticated immunotherapies, a heightened emphasis on managing symptoms over the long term, an increase in research into biologic treatments, greater incorporation of digital tools in dermatology, and breakthroughs in targeted anti-inflammatory medications. Key trends anticipated for the forecast timeframe encompass the wider acceptance of targeted immunomodulatory therapies, an increase in the application of combined topical and systemic treatments, a stronger emphasis on the management of chronic diseases, the broadening of personalized dermatology services, and enhancements in patient education and disease tracking.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24279&type=smp

Which Economic Or Industry Drivers Are Impacting The Lichen Planus Market?

The expanding occurrence of autoimmune diseases is projected to boost the growth of the lichen planus market in the coming period. These conditions involve the immune system erroneously attacking the body’s healthy cells, encompassing ailments like rheumatoid arthritis, lupus, type 1 diabetes, multiple sclerosis, and psoriasis. The rise in autoimmune disease prevalence stems from genetic predisposition, where particular gene variations impact immune system function and lead to connective tissue irregularities. This growing incidence not only signals wider issues in immune regulation but also leads to a higher number of lichen planus diagnoses. For example, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government body, showed that around 514,000 (2.0%) individuals had rheumatoid arthritis in 2022. This condition represented 2.0% of the overall disease burden and 16% of the musculoskeletal conditions burden in 2023, with 1,322 deaths (5.1 deaths per 100,000 population) in 2022, making up 0.7% of all fatalities. Consequently, the increasing prevalence of autoimmune diseases is propelling the expansion of the lichen planus market.

How Is The Lichen Planus Market Segmented Across Key Categories?

The lichen planus market covered in this report is segmented –

1) By Disease Type: Lichen Planus, Oral Lichen Planus, Genital Lichen Planus, Lichen Planus Pigmentosus

2) By Treatment Type: Topical Therapies, Systemic Therapies, Phototherapy

3) By Route Of Administration: Topical, Oral, Intravenous

4) By End User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:

1) By Lichen Planus: Papular Lichen Planus, Hypertrophic Lichen Planus, Actinic Lichen Planus, Linear Lichen Planus, Annular Lichen Planus

2) By Oral Lichen Planus: Reticular Oral Lichen Planus, Erosive Oral Lichen Planus, Atrophic Oral Lichen Planus, Plaque-Like Oral Lichen Planus, Bullous Oral Lichen Planus

3) By Genital Lichen Planus: Erosive Genital Lichen Planus, Papular Genital Lichen Planus, Annular Genital Lichen Planus, Vulvovaginal-Gingival Syndrome

4) By Lichen Planus Pigmentosus: Diffuse Lichen Planus Pigmentosus, Blotchy Lichen Planus Pigmentosus, Linear Lichen Planus Pigmentosus, Perifollicular Lichen Planus Pigmentosus, Flexural Lichen Planus Pigmentosus

Which Upcoming Trends Are Expected To Influence The Lichen Planus Market?

Key players within the lichen planus market are increasingly concentrating on the creation of advanced solutions, notably liposomal formulations, to optimize targeted drug delivery and diminish widespread side effects. These liposomal formulations function as drug delivery mechanisms wherein active ingredients are encased within liposomes—tiny, spherical vesicles formed from lipid bilayers—which improve drug stability, enhance absorption, and facilitate precise delivery while lessening systemic adverse reactions. For instance, in February 2025, Lipella Pharmaceuticals Inc., a US-based biotechnology firm specializing in therapies for severe illnesses, secured US Food and Drug Administration approval for an expanded access program (EAP) for LP-310. This particular product is a liposomal formulation of tacrolimus, developed to offer targeted relief for oral lichen planus (OLP) patients while significantly reducing systemic exposure. The program provides patients with serious or life-threatening conditions and unaddressed medical needs the opportunity to access treatments before their official approval, outside the scope of traditional clinical trials.

Who Are The Dominant Players Shaping The Lichen Planus Market Landscape?

Major companies operating in the lichen planus market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc, AbbVie Inc., Sanofi SA, Bristol-Myers Squibb Company, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd, Amneal Pharmaceuticals Inc., Hikma Pharmaceuticals plc, LEO Pharma A/S, Basilea Pharmaceutica Ltd., UCB S.A., Almirall SA, Lipella Pharmaceuticals Inc.

Read the full lichen planus market report here:

https://www.thebusinessresearchcompany.com/report/lichen-planus-global-market-report

What Are The Top-Performing Regions Within The Lichen Planus Market?

North America was the largest region in the lichen planus market in 2025. The regions covered in the lichen planus market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Lichen Planus Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24279&type=smp

Browse Through More Reports Similar to the Global Lichen Planus Market 2026, By The Business Research Company

Luxury Skincare Market Report 2026

https://www.thebusinessresearchcompany.com/report/luxury-skincare-global-market-report

Liraglutide Market Report 2026

https://www.thebusinessresearchcompany.com/report/liraglutide-global-market-report

Sugar And Confectionery Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/sugar-and-confectionery-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795